Sanofi India Limited Share Price & Analysis

Sanofi India appoints new management team

*Sanofi India appoints new management team.* The company filed a regulatory update under SEBI LODR, indicating a change in leadership. While no financial figures were disclosed, such shifts can influence strategic direction. The move reflects organizational restructuring at the pharma major. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ManagementChange

Supreme Court dismisses Sanofi India's plea in criminal case

*Supreme Court dismisses Sanofi India's petition to quash criminal proceedings.* The ruling raises legal uncertainty and potential liability for the company. Criminal charges, if pursued, could impact operations and reputation. Investors should monitor for further legal developments. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #HIGHIMPACT #LegalCase

Sanofi India reports Q2 and H1 FY26 results

*Sanofi India reports Q2 and H1 FY26 results* released via newspaper publication. Financial performance details for the quarter and half year ended **30th June 2026** are now public. Key metrics like revenue, profit, and guidance will influence near-term trading. Results were in line with regulatory filing norms. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

Sanofi India discloses insider trading regulation update

*Sanofi India discloses insider trading regulation update.* The company filed a disclosure under Regulation 7(2)(a) of SEBI's Prohibition of Insider Trading Regulations, 2015. The filing originates from Sanofi Healthcare India Private Limited, part of the promoter group. This is a routine compliance update with no immediate financial impact. 📊 *STOCKS:* SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulation

Sanofi India discloses insider trading regulation update

*Sanofi India discloses insider trading regulation update.* This filing is under Regulation 7(2)(B) of the SEBI (PIT) Regulations, 2015, pertaining to standard compliance disclosures. No **financial figures** or **material events** are mentioned. It is a routine regulatory update. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulation

Sanofi India shares unaffected by regulatory filing update

*Sanofi India shares unchanged after a routine regulatory filing.* The update pertains to compliance under SEBI Listing Regulations, specifically Regulation 30, with no financial impact disclosed. **No material changes** in operations or management were indicated. Such disclosures are standard for listed entities. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulation

Sanofi India issues regulatory filing under SEBI norms

*Sanofi India issues regulatory filing under SEBI norms.* The company has submitted an intimation pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This is a routine disclosure with no **specific financial figures** or strategic announcements. Traders should monitor for follow-up updates. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Regulatory

Sanofi India hosts analyst call with no major announcements

*Sanofi India hosts analyst call with no major announcements.* The company shared updates during its investor and analyst con. call, focusing on business performance and market outlook. No significant financial revisions or strategic changes were disclosed. Transcript available via NSE corporate filing. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystCall

Sanofi India hosts analyst call for investor updates

*Sanofi India hosts analyst call for investor updates.* The company shared insights during its recent investor and analyst meet. A video recording of the session has been made available. No major announcements or financial updates were disclosed. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AnalystCall

Sanofi India hosts investor and analyst call

*Sanofi India hosts investor and analyst call* to discuss business updates and strategy. The session included a presentation for institutional investors and analysts. No major financial announcements or guidance changes were disclosed. The event is part of routine investor engagement. 📊 *STOCKS:* $SANOFI | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorCall